Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales. Management raises...

PFE beats third-quarter estimates for earnings and sales. It raises 2024 earnings and revenue expectations.

BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.

BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.

GILD's Q3 earnings and sales beat estimates on higher HIV, Veklury, oncology and liver disease drug sales. The stock is trading up.

FOLD's third-quarter 2024 earnings and sales beat the Zacks Consensus Estimate. The company raises its financial guidance for 2024.

DXCM's third-quarter 2024 earnings and revenues surpass expectations, fueled by global growth in CGM adoption, strong Sensor sales and expansion into...

Lower average net selling price and reduced sales volumes for steel products weigh on CLF's Q3 performance.

Upbound delivers strong Q3 results, registering year-over-year growth in revenues and earnings.

Upbound delivers strong Q3 results, registering year-over-year growth in revenues and earnings.